Iceland· IS-IS/1/07/027/01

Boostrix Polio

A diphtherie-pertussis-poliomyelitis-tetanus product containing poliovirus inactivated type 2,pertussis toxoid,tetanus toxoid,poliovirus inactivated type 1,poliovirus inactivated type 3,filamentous haemagglutinin,pertussis pertactin,diphtheria toxoid, registered in Iceland by GlaxoSmithKline Pharma A/S. The same ATC class is registered in 11 of our 19 countries.

ATC J07CA02

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedBoostrix PolioATCJ07CA02REGISTER NO.IS-IS/1/07/027/01PACKS LISTED2CHECKEDSeptember 29, 2026

Where it is registered

Diphtherie-pertussis-poliomyelitis-tetanus is registered in 11 of 19 countries.

Countries holding a registration under ATC J07CA02 (diphtherie-pertussis-poliomyelitis-tetanus), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 7 of them publish a price we can compare per daily dose

Diphtherie-pertussis-poliomyelitis-tetanus · ATC J07CA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Poliovirus inactivated type 2,Pertussis toxoid,Tetanus toxoid,Poliovirus inactivated type 1,Poliovirus inactivated type 3,Filamentous haemagglutinin,Pertussis pertactin,Diphtheria Toxoid
Manufacturer
GlaxoSmithKline Pharma A/S
Country
Iceland (IS)
ATC code
J07CA02
ATC class
Diphtherie-Pertussis-Poliomyelitis-Tetanus
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 2

2 priced
  • ean
    993429
    0,5 ml x10 áf.spr
    ISK 80542
  • ean
    994401
    0,5 ml x1 áf.spr
    ISK 10642

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c03ece18-6757-458a-85fb-7d52fca9f25d
GET /v1/drugs/c03ece18-6757-458a-85fb-7d52fca9f25d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyf, dreifa",
  "source": "lyfjastofnun",
  "atc_raw": "J07CA02",
  "marketed": true,
  "strength": null,
  "ma_number": "IS/1/07/027/01",
  "substance": "Poliovirus inactivated type 2,Pertussis toxoid,Tetanus toxoid,Poliovirus inactivated type 1,Poliovirus inactivated type 3,Filamentous haemagglutinin,Pertussis pertactin,Diphtheria Toxoid",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "39287"
}

See everything about diphtherie-pertussis-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.